Загрузка...

Are AI agents killing the CRO industry, or is this just panic?

Stock markets recently reacted negatively to the rise of AI agents, fearing that pharma companies might move clinical trials in-house and render traditional CROs obsolete. While some analysts dismiss this as overblown, estimates suggest AI-enabled trials could drive significant cost savings of 10 to 15 percent. One industry insider breaks down why the standard narrative misses the nuance of how tech-enabled organizations are actually evolving rather than disappearing.
#CRO #Biotech #ArtificialIntelligence #ClinicalTrials #PharmaTech #StockMarket #FutureOfWork

Видео Are AI agents killing the CRO industry, or is this just panic? канала Dan Sfera
Яндекс.Метрика
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять